Abstract
Background: Atrophic acne scars are a common and refractory dermatological complication that seriously affects patients' physical appearance and quality of life. Aims: This review aims to summarize the latest progress in the pathological mechanism and clinical treatment of atrophic acne scars, discuss the advantages and limitations of various therapies, and propose future research directions. Methods: A narrative review of the literature was conducted using PubMed, focusing on current evidence regarding the pathogenesis and management of atrophic acne scars. Results: The pathogenesis involves persistent inflammation, abnormal dermal collagen remodeling, stem cell dysfunction, and genetic and epigenetic regulation, forming a complex regulatory network. Multiple therapeutic options are available, including laser therapy, microneedling, radiofrequency, surgical techniques, filler injection, chemical peeling, and emerging biological therapies such as stem cells and extracellular vesicles. EV therapy represents a promising emerging regenerative approach, although supporting evidence remains preliminary, and larger controlled studies are required before routine clinical implementation. Conclusions: Multi‐omics, personalized precision treatment, and combined regimens represent promising future directions. This review may inform clinical practice and research on atrophic acne scars.

This publication has 73 references indexed in Scilit: